Abstract:When SARS‐CoV‐2 enters inside the cell by fusion process it encodes few proteins including main protease with the help of cellular ribosomes. This main protease mediates the maturation cleavage of polyproteins at 11 different regions, which is a notable step in virus's life cycle. SARS‐CoV‐2 Mpro is mainly a homo‐dimeric enzyme consisting of three domains. The large substrate‐binding site with a catalytic dyad of His41 and Cys145 is located between chymotrypsin‐like domains I and picornavirus 3C protease‐like domain II. Inhibition of this substrate binding site disrupt the replication process. But being large substrate‐binding site, peptide is more suitable than small molecules for inhibiting this crucial site. The outcome of this computational study displays that the attachment of peptide with Mpro protease can be a good strategy to inhibit the substrate‐binding site which may lead to disruption of replication process of SARS CoV‐2. The COVID‐19 pandemic has been a public health emergency, with deadly forms constantly emerging around the world, highlighting the dire need for highly effective antiviral therapeutics. Peptide therapeutics show significant potential for this viral disease due to their efficiency, safety, and specificity. Here, two thousand seven hundred eight antibacterial peptides were screened computationally targeting the Main protease (Mpro) of SARS CoV‐2. Six top‐ranked peptides according to their binding scores, binding pose were investigated by molecular dynamics to explore the interaction and binding behavior of peptide‐Mpro complexes. The structural and energetic characteristics of Mpro‐DRAMP01760 and Mpro‐DRAMP01808 complexes fluctuated less during a 250 ns MD simulation. In addition, three peptides (DRAMP01760, DRAMP01808, and DRAMP01342) bind strongly to Mpro protein, according to the free energy landscape and principal component analysis. Peptide helicity and secondary structure analysis are in agreement with our findings. Interaction analysis of protein‐peptide complexes demonstrated that Mpro's residue CYS145, HIS41, PRO168, GLU166, GLN189, ASN142, MET49, and THR26 play significant contributions in peptide‐protein attachment. Binding free energy analysis (MM‐PBSA) demonstrated the energy profile of interacting residues of Mpro in peptide‐Mpro complexes. To summarize, the peptides DRAMP01808 and DRAMP01760 may be highly Mpro specific, resulting disruption in a viral replication and transcription. The results of this research are expected to assist future research toward the development of antiviral peptide‐based therapeutics for Covid‐19 treatment.

Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide.

Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase.

Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

REVISITING THE SARS-COV-2 MAIN PROTEASE: A 2023 IN SILICO ODYSSEY IN SEARCH OF POTENTIAL INHIBITORS

Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (Mpro) Using Hexapeptide Substrates

A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link Between Three Residues C22, C44, and K61 is Frequently Observed in the SARS-CoV-2 Main Protease.

Ph-Dependent Conformational Flexibility of the SARS-CoV Main Proteinase (mpro) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses

The Substrate Specificity of SARS Coronavirus 3C-Like Proteinase.

Activation and Maturation of Sars-Cov Main Protease

Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme.

1 H, 13 C and 15 N resonance assignments of SARS-CoV main protease N-terminal domain

Large scale peptide screening against main protease of SARS CoV‐2

C-Terminal Domain of Sars-Cov Main Protease Can Form A 3d Domain-Swapped Dimer

Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-Like Proteinase

Residues On The Dimer Interface Of Sars Coronavirus 3c-Like Protease: Dimer Stability Characterization And Enzyme Catalytic Activity Analysis

Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814

1H, 13C, and 15N Resonance Assignments of the N-terminal Domain of the SARS CoV Nucleocapsid Protein.

The N-Terminal Octapeptide Acts As A Dimerization Inhibitor of Sars Coronavirus 3C-Like Proteinase

Crystal structures of main protease (M pro ) mutants of SARS-CoV-2 variants bound to PF-07304814